menu
    • menu

    Company profile for ImmVira

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    mmvira was founded in Shenzhen China in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago. To develop a broad range of anti-cancer therapies based on genetically engineered viruses and a...
    mmvira was founded in Shenzhen China in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago. To develop a broad range of anti-cancer therapies based on genetically engineered viruses and augmented by cancer specific immune factors or chemotherapeutic agents that can be delivered intratumorally or systemically.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmViraChina Flag
    Country
    Country
    China
    Address
    Address
    10F，Building 2, Silver Star Hi-tech Industrial Park, 1301 Guanguang Rd., Lon...
    Telephone
    Telephone
    (0755)28291816
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bio.immvira.cn/pc/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immvira Reveals High Response In BCG-Unresponsive Bladder Cancer
    Immvira Reveals High Response In BCG-Unresponsive Bladder Cancer

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/high-response-in-bladder-cancer-immvira-announced-its-mvr-t3011-latest-clinical-results-in-bcg-unresponsive-bladder-cancer-patients-at-2025-annual-meeting-of-the-society-of-urologic-oncology-302631544.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    ImmVira Doses First Patient in Ph2 NMIBC Trial
    ImmVira Doses First Patient in Ph2 NMIBC Trial

    10 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immvira-announces-first-patient-dosed-in-a-multi-regional-phase-ii-clinical-trial-evaluating-mvr-t3011-oncolytic-immunotherapy-in-patients-with-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer-nmibc-302477586.html

    PR NEWSWIRE
    10 Jun 2025
    Share Share
    ImmVira Presents Clinical Result of MVR-C5252 at 2025 AACR Meeting
    ImmVira Presents Clinical Result of MVR-C5252 at 2025 AACR Meeting

    27 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immvira-presented-clinical-results-of-oncolytic-product-mvr-c5252-targeting-malignant-glioma-via-convection-enhanced-delivery-at-2025-aacr-annual-meeting-302439115.html

    PR NEWSWIRE
    27 Apr 2025
    Share Share
    ImmVira's MVR-T3011 IT Injection Receives FDA Fast Track Designation
    ImmVira's MVR-T3011 IT Injection Receives FDA Fast Track Designation

    15 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immviras-oncolytic-product-mvr-t3011-it-intratumoral-injection-receives-fda-fast-track-designation-for-hnscc-treatment-302090155.html

    PR NEWSWIRE
    15 Mar 2024
    Share Share
    MVR-T3011 IV Successfully Concludes Phase I Clinical Study
    MVR-T3011 IV Successfully Concludes Phase I Clinical Study

    09 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-first-vaccine-to-prevent-disease-caused-by-chikungunya-virus-301984081.html

    PR NEWSWIRE
    09 Nov 2023
    Share Share
    ImmVira Appoints Howard L. Kaufman, M.D. as Consulting Medical Advisor
    ImmVira Appoints Howard L. Kaufman, M.D. as Consulting Medical Advisor

    22 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immvira-appoints-howard-l-kaufman-md-as-consulting-medical-advisor-301907504.html

    PR NEWSWIRE
    22 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search